Harvard Bioscience Inc (HBIO)
0.6111
+0.02
(+3.21%)
USD |
NASDAQ |
Mar 26, 16:00
0.6092
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Enterprise Value: 59.78M for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Bruker Corp | 8.546B |
| Azenta Inc | 1.200B |
| Bionano Genomics Inc | 0.5253M |
| Akoya Biosciences Inc | 113.38M |
| Kestra Medical Technologies Ltd | 1.184B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.018M |
| Revenue (Quarterly) | 24.56M |
| Total Expenses (Quarterly) | 25.94M |
| Gross Profit Margin (Quarterly) | 57.06% |
| Profit Margin (Quarterly) | 0.07% |
| Earnings Yield | -47.46% |
| Normalized Earnings Yield | -44.56 |